Support for Small Business Innovation Research to Develop New Open and Closed-Loop Automated Technologies for Better Type 1 Diabetes Therapy and Monitoring (SBIR) (R43/R44 Clinical Trial Not Allowed)
The goal of this Funding Opportunity Announcement (FOA) is to stimulate bioengineers, physiologists, bio-behavioral researchers, and designers in academic centers and small businesses to develop new approaches to create devices/components with enhanced accuracy and less patient burden that will represent real advancements regarding safety and effectiveness of glucose control technologies including open and closed loop hormone replacement systems.Guillermo Arreaza-Rubin, M.D. | RFA-DK-18-022
Source: NIDDK Funding Opportunities - Category: Endocrinology Source Type: funding
More News: Academia | Clinical Trials | Diabetes | Diabetes Type 1 | Endocrinology | Funding | Hormones | Small Businesses